Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: Development of Environmental Monitoring Plates – V 2.0

Posted on By

Analytical Method Development: Development of Environmental Monitoring Plates – V 2.0

Standard Operating Procedure for Development of Environmental Monitoring Plates in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/125/2025
Supersedes SOP/AMD/125/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

This SOP defines the procedure for preparation, validation, and usage of environmental monitoring plates (settle plates and contact plates) for microbial monitoring of

cleanroom environments and controlled areas in pharmaceutical manufacturing and analytical areas.

2. Scope

This SOP applies to the Analytical Method Development (AMD) and Microbiology departments responsible for microbiological monitoring of ambient environments, including cleanrooms, HVAC areas, laminar air flow cabinets, and critical production zones.

3. Responsibilities

  • Microbiologist: Prepares media plates, validates their performance, and monitors area contamination levels.
  • Analytical Scientist: Coordinates environmental monitoring requirements during product development and analysis.
  • QA Officer: Reviews data records and ensures regulatory compliance.
  • Head – AMD: Approves media development protocol and ensures periodic validation.
See also  Analytical Method Development: Residual Solvent Estimation by HPLC - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for ensuring the quality, traceability, and readiness of environmental monitoring plates and their usage protocols.

5. Procedure

5.1 Media Selection and Preparation

  1. Use the following media for preparation of monitoring plates:
    • Tryptic Soy Agar (TSA): for total aerobic microbial count
    • Sabouraud Dextrose Agar (SDA): for yeast and mold monitoring
  2. Weigh media as per manufacturer’s instructions and prepare in bulk using purified water.
  3. Sterilize in autoclave at 121°C for 15–20 minutes.
  4. Dispense aseptically into:
    • 90 mm petri dishes for settle plates
    • 55 mm contact plates for surface monitoring
  5. Label with batch number, preparation date, expiry, and type of media.
  6. Document preparation in Annexure-1: Media Preparation Log.

5.2 Plate Quality and Growth Promotion Testing (GPT)

  1. Perform GPT using ATCC cultures:
    • Staphylococcus aureus (ATCC 6538)
    • Bacillus subtilis (ATCC 6633)
    • Candida albicans (ATCC 10231)
  2. Inoculate plates with ≤ 100 CFU and incubate:
    • TSA: 30–35°C for 3 days
    • SDA: 20–25°C for 5 days
  3. Record recovery and morphology in Annexure-2: GPT Record Sheet.

5.3 Sterility Verification and Shelf-Life

  1. Incubate a minimum of 5% of each lot of un-inoculated plates:
    • 20–25°C and 30–35°C for 14 days
  2. Check for contamination. Discard batch if contamination is observed.
  3. Assign a shelf-life of up to 4 weeks under controlled storage (2–8°C) with desiccant packs.
  4. Document in Annexure-3: Sterility Verification Log.
See also  Analytical Method Development: SOP for Ruggedness and Robustness Evaluation - V 2.0

5.4 Usage in Environmental Monitoring

  1. Use settle plates by exposing for 4 hours in cleanroom areas, 1 hour in critical zones.
  2. Use contact plates by pressing gently on surface areas (gloves, walls, equipment) for 10 seconds.
  3. Record sample ID, location, time, and personnel in Annexure-4: Monitoring Usage Log.
  4. Incubate as per media type and inspect for microbial growth.

5.5 Acceptance Criteria

  1. Compare microbial counts to ISO 14644, WHO TRS 961 Annex 6, and internal alert/action limits:
  2. Grade Settle Plate (cfu/4hr) Contact Plate (cfu/plate)
    A <1 <1
    B 5 5
    C 50 25
    D 100 50
  3. Any values exceeding alert/action limits must trigger deviation investigation and CAPA.

6. Abbreviations

  • TSA: Tryptic Soy Agar
  • SDA: Sabouraud Dextrose Agar
  • GPT: Growth Promotion Test
  • cfu: Colony Forming Units
  • SOP: Standard Operating Procedure

7. Documents

  1. Media Preparation Log – Annexure-1
  2. GPT Record Sheet – Annexure-2
  3. Sterility Verification Log – Annexure-3
  4. Monitoring Usage Log – Annexure-4
See also  Analytical Method Development: SOP for Qualification of Reference Standards and Working Standards - V 2.0

8. References

  • USP <1116> – Microbiological Control and Monitoring of Aseptic Environments
  • WHO TRS 961 Annex 6 – GMP for Sterile Pharmaceutical Products
  • ISO 14644-1 and 14698 – Cleanroom Standards

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Media Preparation Log

Media Batch No. Preparation Date Expiry Date Prepared By
TSA TSA0525 18/05/2025 18/06/2025 Sunita Reddy

Annexure-2: GPT Record Sheet

Organism Media CFU Inoculated CFU Recovered Status
B. subtilis TSA 85 80 Pass

Annexure-3: Sterility Verification Log

Media Lot No. Storage Condition Contamination Observed Remarks
TSA TSA0525 2–8°C No Acceptable

Annexure-4: Monitoring Usage Log

Date Location Plate Type Exposure Time Collected By
19/05/2025 Grade B – LAF Hood Settle Plate 1 hr Rajesh Kumar

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Included WHO and ISO-based alert/action limits and plate shelf-life controls Annual SOP Review
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Gel Manufacturing: SOP for Batch Record Review for Gels – V 2.0
Next Post: Biosimilars: SOP for Media Compatibility Assessment – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version